The impact of common and rare EGFR mutations in response to EGFR tyrosine kinase inhibitors and platinum-based chemotherapy in patients with non-small cell lung cancer. (Q53653095)
Jump to navigation
Jump to search
scientific article published on 18 December 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The impact of common and rare EGFR mutations in response to EGFR tyrosine kinase inhibitors and platinum-based chemotherapy in patients with non-small cell lung cancer. |
scientific article published on 18 December 2014 |
Statements
The impact of common and rare EGFR mutations in response to EGFR tyrosine kinase inhibitors and platinum-based chemotherapy in patients with non-small cell lung cancer. (English)
1 reference
Rafael Rosell
1 reference
Oscar Arrieta
1 reference
Andrés Felipe Cardona
1 reference
Luis Corrales
1 reference
Alma Delia Campos-Parra
1 reference
Roberto Sánchez-Reyes
1 reference
Eduardo Amieva-Rivera
1 reference
July Rodríguez
1 reference
Carlos Vargas
1 reference
Hernán Carranza
1 reference
Jorge Otero
1 reference
Nikki Karachaliou
1 reference
Horacio Astudillo
1 reference
CLICaP
1 reference
18 December 2014
1 reference
1 reference
87
1 reference
2
1 reference
169-175
1 reference
Identifiers
1 reference